Hot Topics in Research Ethics Post Trial Responsibilities and Access to Injectable Cabotegravir for PrEP
You are invited to join this webinar!
Advance registration required: Click this link to register
After registering, you will receive a confirmation email containing information about joining the meeting.
Long-acting injectable cabotegravir (CAB-LA) was recently shown in large clinical trials to be a safe and effective way to prevent HIV. However, it has been difficult or impossible for those at risk to access it in many locations around the world. This session will include a brief review about the use of CAB-LA for HIV pre-exposure prophylaxis as well as community concerns and ethical issues raised by the lack of access to it.
This programme is organised by the Master of Health Research Ethics (MOHRE) programme at Universiti Malaya (http://www.mohre.um.edu.my). It is supported by the Fogarty International Center of the United States, National Institutes of Health (Grant R25TW010891) in collaboration with the Berman Institute of Bioethics, Johns Hopkins University.